Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/03/2908351/0/en/Cidara-Therapeutics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/30/2890686/0/en/Cidara-Therapeutics-to-Present-Preclinical-Data-on-CD388-at-ASM-Microbe-2024-Conference.html
https://www.globenewswire.com/news-release/2024/05/15/2882924/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/15/2882849/0/en/Cidara-Therapeutics-Regains-Compliance-with-Nasdaq-Continued-Listing-Rules.html
https://www.globenewswire.com/news-release/2024/04/26/2870437/0/en/Cidara-Therapeutics-Announces-Presentations-Highlighting-Phase-1-and-Phase-2a-Clinical-Data-on-CD388-at-ESCMID-2024.html
https://www.fiercebiotech.com/biotech/cidara-regains-rights-flu-med-after-janssen-makes-good-promise-divest
https://www.globenewswire.com/news-release/2024/04/24/2869086/0/en/Cidara-Therapeutics-Reacquires-Global-Development-and-Commercial-Rights-to-CD388-and-Announces-Private-Placement-Financing-of-240-Million.html
https://www.globenewswire.com/news-release/2024/04/24/2869049/0/en/Cidara-Therapeutics-Announces-Divestiture-of-Rezafungin-to-Mundipharma-to-Focus-on-Advancing-the-Clinical-Development-of-Cloudbreak-DFC-Pipeline.html
https://www.globenewswire.com/news-release/2024/04/22/2867269/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/22/2867265/0/en/Cidara-Therapeutics-Announces-Receipt-of-Nasdaq-Delinquency-Notice.html